“…Based on its structure, chromosomal location, and biochemical properties, mda-7 has been classified as a member of the IL-10 family of cytokines that includes IL-10, IL-19, IL-20, IL-22, and IL-26 and has been redesignated IL-24 (3,4). When expressed at supraphysiological levels, by means of an adenoviral (Ad) expression system (Ad.mda-7), MDA-7/ IL-24 induces growth suppression and apoptosis in a broad spectrum of human cancer cells, including those from melanoma, malignant glioma, fibrosarcoma, and carcinomas of the breast, cervix, colon, rectum, liver, lung, ovary, and prostate, without exerting any deleterious effects on their normal counterparts (5)(6)(7)(8)(9)(10)(11)(12)(13). A phase I trial evaluating Ad.mda-7 (INGN 241) activity by intratumoral injection in patients with advanced solid tumors was performed, indicating that mda-7/IL-24 was safe and could induce as much as 70% apoptosis in tumors after a single injection of recombinant virus and that multiple injections elicited clinical responses (14)(15)(16).…”